[go: up one dir, main page]

BR9910113A - Composições oftálmicas que se transformam em gel, contendo goma xantano - Google Patents

Composições oftálmicas que se transformam em gel, contendo goma xantano

Info

Publication number
BR9910113A
BR9910113A BR9910113-0A BR9910113A BR9910113A BR 9910113 A BR9910113 A BR 9910113A BR 9910113 A BR9910113 A BR 9910113A BR 9910113 A BR9910113 A BR 9910113A
Authority
BR
Brazil
Prior art keywords
gel
xanthan gum
turn
ophthalmic compositions
containing xanthan
Prior art date
Application number
BR9910113-0A
Other languages
English (en)
Inventor
Rajan Bawa
Rex E Hall
Bhagwati P Kabra
James E Teague
Original Assignee
Alcon Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Lab Inc filed Critical Alcon Lab Inc
Publication of BR9910113A publication Critical patent/BR9910113A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Patente de Invenção: <B>''COMPOSIçõES OFTáLMICAS QUE SE TRANSFORMAM EM GEL, CONTENDO GOMA XANTANO''<D>. São descritos veículos para o fornecimento de droga oftálmica que são administráveis como um líquido e que se tornam em gel na ocasião do contato com o olho. Os veículos contêm goma xantano.
BR9910113-0A 1998-04-07 1999-03-26 Composições oftálmicas que se transformam em gel, contendo goma xantano BR9910113A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8100498P 1998-04-07 1998-04-07
PCT/US1999/006106 WO1999051273A1 (en) 1998-04-07 1999-03-26 Gelling ophthalmic compositions containing xanthan gum

Publications (1)

Publication Number Publication Date
BR9910113A true BR9910113A (pt) 2000-12-26

Family

ID=22161189

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9910113-0A BR9910113A (pt) 1998-04-07 1999-03-26 Composições oftálmicas que se transformam em gel, contendo goma xantano

Country Status (18)

Country Link
EP (1) EP1069913B1 (pt)
JP (1) JP4545927B2 (pt)
KR (1) KR100598722B1 (pt)
CN (1) CN1133466C (pt)
AR (1) AR016460A1 (pt)
AT (1) ATE245451T1 (pt)
AU (1) AU740586B2 (pt)
BR (1) BR9910113A (pt)
CA (1) CA2322579C (pt)
DE (1) DE69909768T2 (pt)
DK (1) DK1069913T3 (pt)
ES (1) ES2203103T3 (pt)
NZ (1) NZ506921A (pt)
PT (1) PT1069913E (pt)
TR (1) TR200002848T2 (pt)
TW (1) TWI262797B (pt)
WO (1) WO1999051273A1 (pt)
ZA (1) ZA200004413B (pt)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6261547B1 (en) 1998-04-07 2001-07-17 Alcon Manufacturing, Ltd. Gelling ophthalmic compositions containing xanthan gum
AU2797400A (en) * 1999-01-19 2000-08-07 Dr. Gerhard Mann Chemisch-Pharmazeutische Fabrik Gmbh Artificial lacrimal fluid in gel form
TR200201174T2 (tr) 1999-11-01 2002-08-21 Alcon, Inc. Florokinolon antibiyotik ilacı ve iksantan zamkı içeren farmasötik bileşimler.
ATE291913T1 (de) * 2000-01-25 2005-04-15 Alcon Inc Antiallergische ophthalmische zubereitungen, geeignet zur anwendung mit kontaktlinsen
US6458836B1 (en) 2000-03-16 2002-10-01 Sucampo, A.G. Treatment of ocular hypertension and glaucoma
AU2001241143B2 (en) * 2000-03-16 2005-08-25 Sucampo Ag Composition for use in treatment of ocular hypertension and glaucoma
KR20030023700A (ko) 2000-07-14 2003-03-19 알러간, 인코포레이티드 치료활성 성분을 함유하고 용해도가 증강된 조성물
US8858961B2 (en) 2000-07-14 2014-10-14 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components
PL360707A1 (en) 2000-07-14 2004-09-20 Allergan Inc. Compositions containing alpha-2-adrenergic agonist components
US20020035148A1 (en) * 2000-07-20 2002-03-21 Ryuji Ueno Treatment of ocular hypertension
DE60106619T2 (de) * 2000-07-28 2005-03-17 Alcon, Inc. Pharmazeutische zusammensetzungen enthaltend tobramycin und xanthangummi
AU1770901A (en) * 2000-11-16 2002-05-27 Alcon Lab Inc Combination therapy for lowering and controlling intraocular pressure
AU2002230504A1 (en) 2000-12-20 2002-07-01 Alcon Universal Ltd. Ophthalmic irrigating solution adapted for use in lasik surgery
US7169755B2 (en) 2000-12-20 2007-01-30 Alcon, Inc. Solution for removing cataracts via liquefracture
AU2002232437A1 (en) 2000-12-20 2002-07-01 Alcon Universal Ltd. Ophthalmic lubricating solution adapted for use in lasik surgery
US7084130B2 (en) 2001-12-11 2006-08-01 Alcon, Inc. Intraocular irrigating solution having improved flow characteristics
JP2005519978A (ja) * 2002-03-28 2005-07-07 スキャンポ・アーゲー 高眼圧症および緑内障の処置方法
US7030149B2 (en) * 2002-04-19 2006-04-18 Allergan, Inc. Combination of brimonidine timolol for topical ophthalmic use
EP1358883B8 (en) * 2002-04-30 2007-10-03 Sifi S.p.A Re-epithelializing pharmaceutical compositions containing xanthan gum
US8580851B2 (en) 2002-08-21 2013-11-12 Sucampo Ag Ophthalmic solution
CA2536281C (en) * 2003-08-21 2012-05-15 Sucampo Ag Ophthalmic composition comprising a 15-keto-prostaglandin compound
WO2006035969A1 (ja) * 2004-09-28 2006-04-06 Senju Pharmaceutical Co., Ltd. キサンタンガムおよびアミノ酸を含有する眼科用組成物
WO2007032997A1 (en) * 2005-09-13 2007-03-22 Bausch & Lomb Incorporated Ophthalmic formulation containing loteprednol etabonate for treatment of dry eye
US7875271B2 (en) 2006-03-23 2011-01-25 Senju Pharmaceutical Co., Ltd. Ophthalmic composition comprising xanthan gum and glucose
CA2659687A1 (en) 2006-07-31 2008-02-07 Senju Pharmaceutical Co., Ltd. Aqueous liquid preparation containing amide compound
KR20090063252A (ko) 2006-10-12 2009-06-17 교린 세이야꾸 가부시키 가이샤 향상된 안내 가티플록사신 이행성을 갖는 수성 액제
TWI544934B (zh) * 2008-06-09 2016-08-11 愛爾康研究有限公司 含有氟喹諾酮抗生素藥物之經改良藥學組成物
DE102010009475B4 (de) 2010-02-26 2011-11-24 F. Holzer Gmbh Verfahren zur Herstellung eines dosierbaren applikationsfertigen Präparates
WO2011138801A1 (en) * 2010-05-07 2011-11-10 Sun Pharma Advanced Research Company Ltd. Novel ophthalmic compositions
JP5713791B2 (ja) * 2010-05-12 2015-05-07 テイカ製薬株式会社 眼科用剤
AU2010356098B2 (en) * 2010-06-23 2014-08-14 Alcon Research, Ltd. Topical ophthalmic suspensions containing tobramycin and dexamethasone
US20130149394A1 (en) * 2010-08-27 2013-06-13 Wakamoto Pharmaceutical Co., Ltd. Aqueous ophthalmic composition
WO2016061145A1 (en) 2014-10-13 2016-04-21 Symic Biomedical, Inc. Synthetic proteoglycans for preventing tissue adhesion
WO2016061147A1 (en) 2014-10-13 2016-04-21 John Eric Paderi Luminal vessel coating for arteriovenous fistula
WO2016065083A1 (en) 2014-10-21 2016-04-28 Symic Biomedical, Inc. Peptidoglycans comprising collagen-binding peptides for treating gastroesophageal injury
CN104825386A (zh) * 2015-05-25 2015-08-12 湖北汇瑞药业股份有限公司 一种表皮麻醉凝胶及其制备方法
TW201718028A (zh) 2015-10-13 2017-06-01 賽米克Ｉｐ有限責任公司 Ve-鈣黏蛋白結合性生物結合物
KR101770324B1 (ko) * 2016-11-09 2017-08-22 주식회사태준제약 안압 강하용 점안 조성물
CN109722347B (zh) * 2019-01-03 2020-12-29 山东省药学科学院 一种含有黄原胶的保湿润滑组合物及其应用
KR102678138B1 (ko) * 2022-09-29 2024-06-25 주식회사태준제약 브리모니딘을 포함하는 안과용 조성물
WO2025137749A1 (pt) * 2023-12-27 2025-07-03 Eurofarma Laboratórios S.A. Processo de solubilização de olopatadina e seu uso
CN119318630B (zh) * 2024-10-16 2025-08-22 苏州欧康维视生物科技有限公司 一种阿托品药物组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4136177A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Xanthan gum therapeutic compositions
US4814160A (en) * 1988-03-01 1989-03-21 Colgate-Palmolive Company Non-bleeding striped dentifrice
JP3148256B2 (ja) * 1996-07-08 2001-03-19 エドワード メンデル カンパニー．，インコーポレーテッド 高用量難溶性薬物用持続放出マトリックス

Also Published As

Publication number Publication date
CN1295483A (zh) 2001-05-16
CA2322579A1 (en) 1999-10-14
PT1069913E (pt) 2003-11-28
WO1999051273A1 (en) 1999-10-14
EP1069913B1 (en) 2003-07-23
ES2203103T3 (es) 2004-04-01
ATE245451T1 (de) 2003-08-15
KR100598722B1 (ko) 2006-07-11
HK1031335A1 (en) 2001-06-15
JP4545927B2 (ja) 2010-09-15
KR20010041473A (ko) 2001-05-25
AR016460A1 (es) 2001-07-04
CN1133466C (zh) 2004-01-07
TR200002848T2 (tr) 2001-02-21
ZA200004413B (en) 2001-05-22
JP2002510654A (ja) 2002-04-09
DE69909768D1 (de) 2003-08-28
AU3194799A (en) 1999-10-25
DE69909768T2 (de) 2004-06-17
EP1069913A1 (en) 2001-01-24
NZ506921A (en) 2002-02-01
DK1069913T3 (da) 2003-11-17
TWI262797B (en) 2006-10-01
AU740586B2 (en) 2001-11-08
CA2322579C (en) 2001-08-28

Similar Documents

Publication Publication Date Title
BR9910113A (pt) Composições oftálmicas que se transformam em gel, contendo goma xantano
AR020633A1 (es) Parche cosmetico, farmaceutico o dermatologico.
BR0007008A (pt) Dispositivo para a aplicação de um produto sobre as fibras queratìnicas, notadamente os cìlios ou as sobrancelhas
BR0116037A (pt) Soluções de acondicionamento de lentes de contato
UY27940A1 (es) Formulacion de anticuerpos humanos para el tratamiento de trastornos asociados con tnf-a
BR9909565A (pt) Derivados bicìclicos do ácido hidroxâmico
BR9906758A (pt) Método e composição para transferir zinco para a membrana nasal
DK0739197T3 (da) Konserverede oftalmiske lægemiddelpræparater, som indeholder polymere kvaternære ammoniumforbindelser
BR0116500A (pt) Válvula de vedação de elemento único para um sistema de suporte respiratório
BR0007147A (pt) Composição de tensìdio contendo tensìdio gemini e co-anfifila, sua preparação e aplicação
BRPI0007487B8 (pt) difenil-uréias substituídas com w-carbóxi-arilas como inibidores de raf cinase
BR0105899A (pt) Agente cosmético pulverulento e processo para a sua preparação
BR0012869A (pt) Forma de dosagem farmacêutica de componentes múltiplos
BRPI0411052A (pt) dispositivo ocular para aplicação variável de princìpios ativos controlada por corrente
BR0014203A (pt) Formulações de suspensão tópicas contendo ciprofloxacina e dexametasona
ID26033A (id) Metode penstabilan komposisi bahan farmasi dengan penggunaan khusus dari antioksidan
BR9604878A (pt) Preparado oftálmico em gel gotejável estéril e processo para sua preparação
ES2179910T3 (es) Modificacion cristalina del cdch, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
PT991654E (pt) Novos derivados de 2-(iminometil)amino-fenilo sua preparacao sua aplicacao como medicamentos e composicoes farmaceuticas que os contem
ES2190246T3 (es) Nuevos compuestos de tiazolopirimidina.
BR9916259A (pt) Composição lìquida aquosa para serviço pesado transparente ou translúcida em uma garrafa lìmpida, e, processo para evitar a degradação de enzima na mesma
BR9910129A (pt) Composição compatìvel com gel macio contendo retinol
FI972308A0 (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
BR9914158A (pt) Composição antibiótica para o tratamento dos olhos, ouvidos e nariz
BR9914530A (pt) Aplicação de composição oftálmica compreendendo vitamina a e vitamina e

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DA INT.CL: A61K 47/36, A61K 9/08, A61P 27/02

Ipc: A61K 47/36 (2009.01), A61K 9/08 (2009.01), A61P 27

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFERIDO O PEDIDO COM BASE NOS ARTIGOS 8O, 13 E 25 DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.